The GEO Group Inc
GEO
CoreCivic, Inc.
CXW
Eli Lilly and Co
LLY
UnitedHealth
UNH
Tractor Supply
TSCO
US Stock MarketDetailed Quotes
CSCI COSCIENS Biopharma
- 3.216
- -0.217-6.31%
Trading Jan 8 10:55 ET
10.05MMarket Cap-0.72P/E (TTM)
3.512High3.216Low4.91KVolume3.400Open3.433Pre Close16.46KTurnover0.17%Turnover RatioLossP/E (Static)3.12MShares11.10052wk High0.50P/B9.07MFloat Cap2.50052wk Low--Dividend TTM2.82MShs Float690000.000Historical High--Div YieldTTM8.64%Amplitude2.500Historical Low3.350Avg Price1Lot Size
COSCIENS Biopharma Key Stats
EPS
According to the latest financial report of COSCIENS Biopharma, the latest earnings per share (TTM) for the company is -1.85. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about COSCIENS Biopharma's free cash flow? The latest report shows it as -7.91M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of COSCIENS Biopharma shows that the company's current ratio is 3.46, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of COSCIENS Biopharma, the quick ratio is 2.70, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of COSCIENS Biopharma? The latest ROE figure is -24.89%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of COSCIENS Biopharma, the total asset return on investment (ROA) is -12.27%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check COSCIENS Biopharma's latest financial report to see how their gross margin is doing - currently at 51.15%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of COSCIENS Biopharma, the net profit margin is -307.59%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.